Skip to content

Validating and realising a clinically tested A-EMDR application for postpartum traumas

Validating and realising a clinically tested A-EMDR application for postpartum traumas - A-EMDR application for postpartum traumas

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON56920
Enrollment
20
Registered
2024-07-24
Start date
2024-12-12
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

(1) postpartum trauma

Interventions

The intervention consists of a maximum of 4 EMDR sessions of 45 minutes each using an e-Health intervention based on traditional EMDR. The sessions take place over a period of 3 weeks, with a 1-week

Sponsors

Radboud Universitair Medisch Centrum
Lead Sponsor

Eligibility

Age
18 Years to 64 Years

Inclusion criteria

Inclusion criteria: Women (>=18 years) who have recently given birth at Radboudumc or are currently in care at Radboudumc's POP clinic, and who have a negative or traumatic childbirth experience within the first +-6 to 12 weeks postpartum.

Exclusion criteria

Exclusion criteria: Current or past psychotic disorder

Design outcomes

Primary

MeasureTime frame
Structured interviews and questionnaires will be conducted to collect qualitative data on the feasibility of the intervention, including insights into the process, advantages and disadvantages, and patients' experiences of the application.

Secondary

MeasureTime frame
Additional questionnaires are administered on comorbid symptoms (depressive symptoms (IDS) and anxiety symptoms (STAI), general functioning (OQ-45), and quality of life (WHODAS). This will allow us to investigate whether specific subgroups may influence feasibility and whether these scores change clinically. Furthermore, the trial will examine the extent to which traumatic events evoke no or significantly reduced emotional reactions in the patient, as measured by the PTSD Checklist (PCL-5), allowing for a conservative assessment of efficacy.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP) · Data processed: Jul 3, 2026